31 January 1996 Independent pathway for inclusion complexes of porphyrinoid drugs in tumors: the separation from the lipoprotein pathway in plasma
Author Affiliations +
Abstract
Phthalocyanines and m-TPPs were substituted with two or three t-butyl phenyl anchor groups to build up inclusion complexes with dimeric (beta) -cyclodextrins. These complexes proved to be stable enough to hinder complexation of the porphyrinoids with plasma lipoproteins and, so, offer an independent pathway to transfer porphyrinoids to photosensitize tumor tissue.
© (1996) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Joerg G. Moser, Joerg G. Moser, Anja Ruebner-Heuermann, Anja Ruebner-Heuermann, Andrea Weitemeyer, Andrea Weitemeyer, Ulrike Michelsen, Ulrike Michelsen, Dieter Woehrle, Dieter Woehrle, Angelika C. Rueck, Angelika C. Rueck, Wolfgang S. L. Strauss, Wolfgang S. L. Strauss, Dieter Kirsch, Dieter Kirsch, Sonja Andrees, Sonja Andrees, Chrs. Schroers, Chrs. Schroers, } "Independent pathway for inclusion complexes of porphyrinoid drugs in tumors: the separation from the lipoprotein pathway in plasma", Proc. SPIE 2625, Photochemotherapy: Photodynamic Therapy and Other Modalities, (31 January 1996); doi: 10.1117/12.230980; https://doi.org/10.1117/12.230980
PROCEEDINGS
8 PAGES


SHARE
Back to Top